Your browser doesn't support javascript.
loading
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
Packer, Milton; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Ferreira, João Pedro; Pocock, Stuart J; Carson, Peter; Anand, Inder; Doehner, Wolfram; Haass, Markus; Komajda, Michel; Miller, Alan; Pehrson, Steen; Teerlink, John R; Brueckmann, Martina; Jamal, Waheed; Zeller, Cordula; Schnaidt, Sven; Zannad, Faiez.
Afiliação
  • Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX (M.P.).
  • Anker SD; Imperial College, London, UK (M.P.).
  • Butler J; Department of Cardiology and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany (S.D.A., W.D.).
  • Filippatos G; Department of Medicine, University of Mississippi School of Medicine, Jackson (J.B.).
  • Ferreira JP; National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Greece (G.F.).
  • Pocock SJ; Université de Lorraine, Inserm INI-CRCT, CHRU, Nancy, France (J.P.F., F.Z.).
  • Carson P; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, UK (S.J.P.).
  • Anand I; Washington DC Veterans Affairs Medical Center (P.C.).
  • Doehner W; Department of Cardiology, University of Minnesota, Minneapolis (I.A.).
  • Haass M; Department of Cardiology and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany (S.D.A., W.D.).
  • Komajda M; Theresienkrankenhaus and St.Hedwig-Klinik, Mannheim, Germany (M.H.).
  • Miller A; Department of Cardiology, Hospital Saint Joseph, Paris, France (M.K.).
  • Pehrson S; University of Florida, Jacksonville (A.M.).
  • Teerlink JR; Department of Cardiology, University Hospital, Rigshospitalet, Copenhagen, Denmark (S.P.).
  • Brueckmann M; Section of Cardiology, San Francisco Veterans Affairs Medical Center, CA (J.R.T.).
  • Jamal W; School of Medicine, University of California, San Diego (J.R.T.).
  • Zeller C; Boehringer Ingelheim International GmbH, Ingelheim, Germany (M.B., W.J., C.Z.).
  • Schnaidt S; Boehringer Ingelheim International GmbH, Ingelheim, Germany (M.B., W.J., C.Z.).
  • Zannad F; Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany (D.M., S.S.).
Circulation ; 143(4): 326-336, 2021 01 26.
Article em En | MEDLINE | ID: mdl-33081531
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2021 Tipo de documento: Article